Clinical Trials
75 trialsCHRU-WCMC
University Hospital, Lille
Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor
Lahore General Hospital
GuidePath
Novartis
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
CheckMate 914
Bristol-Myers Squibb
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
GTN
Queen's University
Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor
Endocyte
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
JAVA-P
University Hospitals Bristol and Weston NHS Foundation Trust
Immunotherapy Study for Metastatic Renal Cell Cancer
Lumos Pharma
RB-PSMA
University Hospital, Brest
PF-03446962 in Relapsed or Refractory Urothelial Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Roswell Park Cancer Institute
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers
Mansoura University
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Incyte Corporation
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.
Mansoura University
Cabozantinib in Advanced Solid Malignancies
Massachusetts General Hospital
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Jonsson Comprehensive Cancer Center
Aflac ST0901
Emory University
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
Fred Hutchinson Cancer Center
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Fred Hutchinson Cancer Center
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Acrotech Biopharma Inc.
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Mansoura University
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Celgene
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Children's Oncology Group
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Fred Hutchinson Cancer Center
DaBlaCa-11
Aarhus University Hospital
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
IGPC-3
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma
Idera Pharmaceuticals, Inc.
Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
Masonic Cancer Center, University of Minnesota
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Children's Oncology Group
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
Ankara Training and Research Hospital
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
Fred Hutchinson Cancer Center
Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients
University of Lausanne Hospitals
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
University of Louisville
GVHD
Fred Hutchinson Cancer Center
Markers of Response to Intravesical Bladder Cancer Therapy
M.D. Anderson Cancer Center
ELAAT
Ontario Clinical Oncology Group (OCOG)
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Children's Oncology Group
High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy
Memorial Sloan Kettering Cancer Center
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Rutgers, The State University of New Jersey
Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned
Cellectar Biosciences, Inc.
MDX1106-01
Bristol-Myers Squibb
iCAT for Recurrent/Refractory/HR Solid Tumors
Dana-Farber Cancer Institute
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Children's Oncology Group